These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7724490)

  • 21. Feasibility study on spray-drying protein pharmaceuticals: recombinant human growth hormone and tissue-type plasminogen activator.
    Mumenthaler M; Hsu CC; Pearlman R
    Pharm Res; 1994 Jan; 11(1):12-20. PubMed ID: 8140042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pig collagen peptide fraction. A unique material for maintaining biological activity during lyophilization and during storage in the liquid state.
    Gaffney PJ; Edgell TA; Dawson PA; Ford AW; Stocker E
    J Pharm Pharmacol; 1996 Sep; 48(9):896-8. PubMed ID: 8910848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of stable lyophilized protein drug products.
    Remmele RL; Krishnan S; Callahan WJ
    Curr Pharm Biotechnol; 2012 Mar; 13(3):471-96. PubMed ID: 22283723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation.
    Chang BS; Beauvais RM; Dong A; Carpenter JF
    Arch Biochem Biophys; 1996 Jul; 331(2):249-58. PubMed ID: 8660705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determining the optimum residual moisture in lyophilized protein pharmaceuticals.
    Hsu CC; Ward CA; Pearlman R; Nguyen HM; Yeung DA; Curley JG
    Dev Biol Stand; 1992; 74():255-70; discussion 271. PubMed ID: 1592175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation development of lyophilized, long-term stable siRNA/oligoaminoamide polyplexes.
    Kasper JC; Troiber C; Küchler S; Wagner E; Friess W
    Eur J Pharm Biopharm; 2013 Oct; 85(2):294-305. PubMed ID: 23747745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of storage stability of lyophilized actin using combinations of disaccharides and dextran.
    Allison SD; Manning MC; Randolph TW; Middleton K; Davis A; Carpenter JF
    J Pharm Sci; 2000 Feb; 89(2):199-214. PubMed ID: 10688749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying.
    Sarciaux JM; Mansour S; Hageman MJ; Nail SL
    J Pharm Sci; 1999 Dec; 88(12):1354-61. PubMed ID: 10585234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-gamma.
    Webb SD; Cleland JL; Carpenter JF; Randolph TW
    J Pharm Sci; 2003 Apr; 92(4):715-29. PubMed ID: 12661058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time in situ monitoring of lysozyme during lyophilization using infrared spectroscopy: dehydration stress in the presence of sucrose.
    Remmele RL; Stushnoff C; Carpenter JF
    Pharm Res; 1997 Nov; 14(11):1548-55. PubMed ID: 9434273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moisture sorption behavior of selected bulking agents used in lyophilized products.
    Fakes MG; Dali MV; Haby TA; Morris KR; Varia SA; Serajuddin AT
    PDA J Pharm Sci Technol; 2000; 54(2):144-9. PubMed ID: 10822985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation on formulation and preparation of adenovirus encoding human endostatin lyophilized powders.
    Chen S; Guo D; Guo B; Liu J; Shen Y; Xu X; Huang W; Guo S
    Int J Pharm; 2012 May; 427(2):145-52. PubMed ID: 22234038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Split-Cakes, Still Delicious.
    Lam P; Patapoff TW
    PDA J Pharm Sci Technol; 2019; 73(1):16-29. PubMed ID: 30158240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Freezing process influences cake appearance of a lyophilized amorphous protein formulation with low solid content and high fill configuration.
    Lu X; Kulkarni SS; Dong H; Tang Y; Yi L; Gupta S
    Int J Pharm; 2023 Apr; 636():122803. PubMed ID: 36894041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody.
    Abdul-Fattah AM; Truong-Le V; Yee L; Nguyen L; Kalonia DS; Cicerone MT; Pikal MJ
    J Pharm Sci; 2007 Aug; 96(8):1983-2008. PubMed ID: 17286290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Freezing on Lyophilization Process Performance and Drug Product Cake Appearance.
    Esfandiary R; Gattu SK; Stewart JM; Patel SM
    J Pharm Sci; 2016 Apr; 105(4):1427-33. PubMed ID: 27019959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations.
    Webb SD; Golledge SL; Cleland JL; Carpenter JF; Randolph TW
    J Pharm Sci; 2002 Jun; 91(6):1474-87. PubMed ID: 12115847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of controlled ice nucleation on process performance and quality attributes of a lyophilized monoclonal antibody.
    Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA; Shah RB
    Int J Pharm; 2013 Jun; 450(1-2):70-8. PubMed ID: 23618961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of product temperature during primary drying on the long-term stability of lyophilized proteins.
    Passot S; Fonseca F; Barbouche N; Marin M; Alarcon-Lorca M; Rolland D; Rapaud M
    Pharm Dev Technol; 2007; 12(6):543-53. PubMed ID: 18161627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing the Conformation of an IgG1 Monoclonal Antibody in Lyophilized Solids Using Solid-State Hydrogen-Deuterium Exchange with Mass Spectrometric Analysis (ssHDX-MS).
    Moussa EM; Singh SK; Kimmel M; Nema S; Topp EM
    Mol Pharm; 2018 Feb; 15(2):356-368. PubMed ID: 29355022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.